公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2009 | Phase i and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies | CHIA-CHI LIN ; Beeram M.; Rowinsky E.K.; Takimoto C.H.; Ng C.M.; Geyer Jr. C.E.; Denis L.J.; De Bono J.S.; Hao D.; Tolcher A.W.; Rha S.-Y.; Jolivet J.; Patnaik A. | Cancer Chemotherapy and Pharmacology | 2 | 2 | |
2020 | Sequential afatinib and osimertinib in patients with EGFR mutation-positive non-small-cell lung cancer: Final analysis of the GioTag study | Hochmair M.J.; Morabito A.; Hao D.; Yang C.-T.; Soo R.A.; CHIH-HSIN YANG ; Gucalp R.; Halmos B.; M?rten A.; Cufer T. | Future Oncology | 49 | 45 |